Gün: 11 Mart 2022

Participation in the “9th International Pharmaceutical Chemistry: Pharmaceutical Active Substance Design, Synthesis, Production and Standardization Congress” held on 8-11 April 2021, with the poster presentation of two products developed at the Arion Pharmaceuticals R&D Center. Our poster titles are: Investigation of the Efficacy of Beeseba in Naturally Infected Honey Bee Colonies with Vairimorpha (Nosema) ceranae… Okumaya devam et BEESEBA WINS AWARD AT 9TH INTERNATIONAL PHARMACEUTICAL CHEMISTRY CONGRESS

Turkish manufacturer Bavet Pharmaceuticals which had partnered up in 2012 for 50 percent of its shares with NBK (National Bank of Kuwait) -one of the largest financial institutions in the Middle East- has now bought back all of its shares. Bavet Pharmaceuticals has been active in the fields of animal and environmental health since 2000,… Okumaya devam et BAVET RETRIEVED ITS SHARES FROM NBK!

KUWAIT NBK SOLD ITS SHARES IN BAVET ILAC.. It was announced that the shares of Kuwaiti NBK in Bavet İlaç were sold with the statements “Bavet bought back the 50 percent shares controlled by NBK. Thus, after 8 years, NBK completed its exit from the Turkish company Bavet”. Thus, the National Bank of Kuwait (NBK)… Okumaya devam et BAVET ILAC’S SHARES, BAVET’S AGAIN..!